€500M class action lawsuit against NOLOTIL painkiller manufacturer Boehringer and distributers

The medication NOLOTIL is one of the most widely distributed painkillers worldwide. However, its use has been prohibited in some countries because of adverse side-effects. To this day, NOLOTIL is still prescribed for acute pain in Spain, despite the potentially severe side-effects.

International press conference, Barcelona, 28th November 2018, 01:00 PM

The incidence of victims suffering side-effects from Nolotil ingestion has become more frequent in Spain, a trend identified as a result of the private initiative of activist Cristina García del Campo, and the recent fatalities of a reported 10 British tourists prescribed NOLOTIL. The Spanish health authority “Agencia Española de Medicamentos y Productos Sanitarios (AEMPS)” has latterly intervened and has issued guidelines to hospitals, medical clinics and pharmacies effectively prohibiting the sale or prescription of NOLOTIL to tourists.

An association of NOLOTIL victims, ADAF,  (Asociación De Afectados por Fármacos) has been founded on the initiative of  Cristina García del Campo to further raise awareness of Nolotil issues and to proceed legally against the manufacturer and distributors of NOLOTIL in the form of a class-action lawsuit and various individual suits. There are already more than 200 victim reports and the number is increasing daily. To date, the estimated personal and material damages is already at more than €500M.

The international law firm of De Micco & Friends, based in Palma de Mallorca, has been assigned the brief of legally representing this case. Experienced in large claims, De Micco & Friends will represent the ADAF association in the class action and act for individual claimants.

Because of the legal position in Spain, victims who are not resident in Spain are eligible to assert their claims in the class action and as individual claimants. NOLOTIL victims can find further information at www.lawyers-auditors.com/nolotil.html and can register their interest without obligation.

Press Conference, Barcelona, 28th November 2018, 1.00 PM

ADAF invites the international press to attend its inaugural press conference, where information regarding the latest situation and activities will be announced. Also, victims of NOLOTIL will be present at the press conference to provide their reaction.

Place:       Col·legi de Periodistes de Catalunya
Time:        Start at 1:00 PM
Address:  Rambla de Catalunya 10, 08007 Barcelona.

Journalists can register at the following website:

http://www.lawyers-auditors.com/nolotil_press.html